Physician profile

Ali Aboufares

Interventional Cardiology · New York, NY

NPI 1508837287

$145,286.25

in general payments reported to CMS, 2019-2025

43 companies · $32K in 2025

The $32K reported for 2025 was more than what 95% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).

See the full distribution for Interventional Cardiology

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Long Term Medical Supply Or Device Loan$71,540.00
Food and Beverage$3,402.36
Consulting Fee$500.00

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Angiodynamics, INC. $131,222.01 2019-2025 Venacure 1470 Pro, Auryon Laser System 100-120 Vac, Venacure 1470 Pro
Cardiovascular Systems INC. $3,128.93 2019-2022
Boston Scientific Corporation $1,619.20 2019-2025 Varithena Administration Pack, Lux-Dx Insertable Cardiac Monitor
Novartis Pharmaceuticals Corporation $1,033.12 2019-2025
Janssen Pharmaceuticals, INC $929.77 2019-2024 Xarelto
Amgen INC. $851.65 2019-2025 Repatha, Repatha
Abbott Laboratories $668.44 2021-2025 Jot Dx, Aveir
Medtronic Vascular, INC. $653.96 2019-2020
Philips North America LLC $521.40 2022-2024 (5028) Igt Devices Systems Undivided
Medtronic, INC. $467.99 2021-2024 Hawkone, Venaseal
Astrazeneca Pharmaceuticals LP $450.83 2021-2024 Farxiga
Esperion Therapeutics, INC. $420.87 2020-2022
Tactile Systems Technology INC $385.00 2020-2025 Flexitouch Plus, Nimbl, Entre Plus
Pfizer INC. $359.40 2019-2025
Terumo Medical Corporation $343.14 2019-2023 Metacross Otw, Angio-Seal, Azur Cx Detachable
Show all 43 companies
CompanyGeneral paymentsYearsTop products
Merck Sharp & Dohme LLC $338.62 2021-2025 Verquvo
Organogenesis INC. $271.19 2021-2022
Corcept Therapeutics $219.61 2025 Korlym
Biocompatibles, INC. $126.80 2019
Janssen Scientific Affairs, LLC $122.00 2021
Biotissue Holdings INC. $110.58 2022
Alnylam Pharmaceuticals INC. $104.27 2025 Amvuttra
Cardinal Health 200 LLC $89.36 2019
Sun Pharmaceutical Industries INC. $89.29 2022
Bard Peripheral Vascular, INC. $83.29 2024 Venclose Maven Catheter
Recor Medical INC $82.13 2025 Paradise Ultrasound Renal Denervation System
E.R. Squibb & Sons, L.L.C. $77.27 2023-2025 Eliquis
Lilly USA, LLC $64.87 2020-2023 Mounjaro
Lexicon Pharmaceuticals, INC. $60.22 2024
Boehringer Ingelheim Pharmaceuticals, INC. $43.91 2023-2025 Jardiance
Catheter Precision, INC. Fka Ra Medical Systems, INC. $42.12 2019
Novo Nordisk INC $40.77 2023 Ozempic, Wegovy
Kestra Medical Technology Services, INC. $40.46 2024 Assure Wcd
Cordis US Corp. $38.94 2024 Mynx Venous Vcd
Amarin Pharma, INC. $33.54 2020
Cagent Vascular INC $25.84 2023 Serrantor
Vertex Pharmaceuticals Incorporated $22.79 2025
Heartflow, INC. $22.62 2025
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $22.08 2020
Bayer Healthcare Pharmaceuticals INC. $20.73 2022
Biotronik INC. $17.23 2022
Abbvie INC. $16.53 2021
Reflow Medical INC $3.48 2024

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Ali Aboufares

$145,286.25

in general payments reported 2019-2025

Years
2019-2025
Top company
Angiodynamics, INC.
Context
The $32K reported for 2025 was more than what 95% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).

https://glasscript.com/doctor/295474/ali-aboufares

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.